National Cancer Institute; Notice of Closed Meetings, 20900 [2019-09736]

Download as PDF 20900 Federal Register / Vol. 84, No. 92 / Monday, May 13, 2019 / Notices would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Integrative Health Special Emphasis Panel; Promoting Research on Music and Health. Date: June 19, 2019. Time: 8:00 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, Salon H, 5701 Marinelli Road, Rockville, MD 20852. Contact Person: Pamela Eugenia Jeter, Ph.D., Scientific Review Officer, Office of Scientific Review, Division of Extramural Activities, NCCIH, NIH, 6707 Democracy Boulevard, Suite 401, Bethesda, MD 20892— 547, 301–435–2591, pamela.jeter@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS) Dated: May 7, 2019. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–09739 Filed 5–10–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Amended Notice of Meeting jbell on DSK3GLQ082PROD with NOTICES Notice is hereby given of a change in the meeting of the Council of Councils, May 17, 2019, 08:15 a.m. to May 17, 2019, 04:00 p.m., National Institutes of Health, The Cloisters Building, 1 Cloisters Court, Bethesda, MD 20892 which was published in the Federal Register on February 08, 2019, 84 FR 2889. The meeting notice is amended to change the open and closed session meeting times as follows: The morning open session end time will change from 12:00 p.m. to 11:30 a.m.; the closed session will change from 12:00 p.m.– 1:30 p.m. to 11:45 a.m.–12:15 p.m.; and the afternoon open session start time will change from 1:30 p.m. to 1:15 p.m. Dated: May 7, 2019. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–09734 Filed 5–10–19; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 16:29 May 10, 2019 Jkt 247001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI R38 Review. Date: June 21, 2019. Time: 10:30 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: NCI Shady Grove, 9609 Medical Center Drive, Room 7W110, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Sanita Bharti, Ph.D. Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W122 Bethesda, MD 20892–9750 240–276–5909 sanita.bharti@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel Validation of Cancer Markers (UH2/UH3). Date: June 26, 2019. Time: 12:00 p.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: NCI Shady Grove, 9609 Medical Center Drive, Room 7W244, Rockville, MD 20850 (Telephone Conference Call). Contact Person: John P. Cairns, Ph.D. Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W244 Bethesda, MD 20892–9750 240–276–5415 paul.cairns@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–7: NCI Clinical and Translational R21 and Omnibus R03. Date: June 28, 2019. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: NCI Shady Grove, 9609 Medical Center Drive, Room 7W640, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Saejeong J. Kim, Ph.D. Scientific Review Officer, Special Review Branch, Division of Extramural Activities, PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W640 Bethesda, MD 20892–9750 240–276–5179 saejeong.kim@ nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; UE4/U24 Review. Date: July 9, 2019. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: NCI Shady Grove, 9609 Medical Center Drive, Room 7W110, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Robert E. Bird, Ph.D. Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W110 Bethesda, MD 20892–9750 240–276–6344 birdr@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Advancing Cancer Immunotherapy by MitigatingImmune related adverse events. Date: July 17, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike Rockville, MD 20852. Contact Person: Shari W. Campbell, DPM, MSHS Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W612 Bethesda, MD 20892–9750 240–276–7381 shari.campbell@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: May 7, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–09736 Filed 5–10–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., E:\FR\FM\13MYN1.SGM 13MYN1

Agencies

[Federal Register Volume 84, Number 92 (Monday, May 13, 2019)]
[Notices]
[Page 20900]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-09736]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R38 Review.
    Date: June 21, 2019.
    Time: 10:30 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NCI Shady Grove, 9609 Medical Center Drive, Room 7W110, 
Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Sanita Bharti, Ph.D. Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W122 
Bethesda, MD 20892-9750 240-276-5909 [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Validation of Cancer Markers (UH2/UH3).
    Date: June 26, 2019.
    Time: 12:00 p.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NCI Shady Grove, 9609 Medical Center Drive, Room 7W244, 
Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: John P. Cairns, Ph.D. Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W244 
Bethesda, MD 20892-9750 240-276-5415 [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-7: NCI Clinical and Translational R21 and Omnibus R03.
    Date: June 28, 2019.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NCI Shady Grove, 9609 Medical Center Drive, Room 7W640, 
Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Saejeong J. Kim, Ph.D. Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W640 
Bethesda, MD 20892-9750 240-276-5179 [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; UE4/U24 Review.
    Date: July 9, 2019.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NCI Shady Grove, 9609 Medical Center Drive, Room 7W110, 
Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Robert E. Bird, Ph.D. Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W110 
Bethesda, MD 20892-9750 240-276-6344 [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Advancing Cancer Immunotherapy by Mitigating-Immune related 
adverse events.
    Date: July 17, 2019.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike 
Rockville, MD 20852.
    Contact Person: Shari W. Campbell, DPM, MSHS Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH 9609 Medical 
Center Drive, Room 7W612 Bethesda, MD 20892-9750 240-276-7381 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 7, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-09736 Filed 5-10-19; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.